SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited
Share · INE812G01025 (XBOM)
Overview
No Price
Closing Price XBOM 20.10.2025: 290,90 INR
20.10.2025 09:59
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from SMS Pharmaceuticals Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
SMSPHARMA.BO
INR
20.10.2025 09:59
290,90 INR
-1,80 INR
-0,61 %
Share Float & Liquidity
Free Float 4,94 %
Shares Float 4,38 M
Shares Outstanding 88,71 M
Company Profile for SMS Pharmaceuticals Limited Share
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Company Data

Name SMS Pharmaceuticals Limited
Company SMS Pharmaceuticals Limited
Website https://www.smspharma.com
Primary Exchange XBOM MSE
ISIN INE812G01025
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Ramesh Babu Potluri
Market Capitalization 20 Mrd.
Country India
Currency INR
Employees 1,2 T
Address Plot No. 72, 500034 Hyderabad
Dividends from 'SMS Pharmaceuticals Limited'
Ex-Date Dividend per Share
22.09.2025 0,40 INR

Ticker Symbols

Name Symbol
MSE SMSPHARMA.BO
More Shares
Investors who hold SMS Pharmaceuticals Limited also have the following shares in their portfolio:
CREDIT AGRI. 22/27 MTN
CREDIT AGRI. 22/27 MTN Bond
THE9 LTD
THE9 LTD Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025